Additionally, these medications slow gastric emptying, which contributes to improved postprandial glucose control and promotes satiety
According to FDA guidance, GLP-1 medications are not recommended for people who have: Pregnancy, because safety data are limited and pregnancy requires appropriate weight gain and nutrient storage A prior history of pancreatitis, due to a risk of triggering inflammation of the pancreas A history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 (MEN2), a rare genetic condition linked to thyroid cancer in animal studies A clinician will review your medical history carefully to determine whether these medications are appropriate for you
The Lancet said in an article in February: The practice of microdosing drugs is not new, but there is no evidence that it works for obesity. Ann Marie Defnet, a bariatric surgeon at Northwell Health, New York states largest healthcare provider, says in its health publication the Well: Clinical trials are where we figure out whether a treatment is both effective and safe
GLP-1 medications do this by increasing the amount of insulin a body creates, which helps keep blood sugar in a desirable range and makes you feel full after eating